NSPR still getting beat downNow like you and many others I'm shocked by NSPR price action, so what could have caused it? Well theres one and that was the FDA IDE approval, yet today was ann that they got the full FDA IDE approval green light.
News
-Got FDA IDE approval in the US today
-Last week they where at LD Micro 500 they gave us some company insights
1: Theres already sales in Brazil for next er. At this time er expectations didn't factor that in, so it is nearly 100% they will be making money instead of losing money.
2: They were very confident in getting the FDA IDA approval last week along with the expansion in France and Asia. Can be shown on the company website roadmap.
TA
Now the news is bullish, yet why hasn't price action reflect that? Well only thing it can be said is that people waited for the FDA IDE approval too long, so where can we go from here?
-Well be shot up 40% this morning so even though I have resistance lines from .4194-.4594, it looks like its a very week in the grandscale of this company, so are primary resistance will be .4397-.4594 with .4922 being the true goal to go full rocket. On webull we went passed it, yet on tradingview we didn't so I'll stand with .4922 being the biggest hurdle.
-Support is nothing since we kept waterfalling lower, yet if any support it ranges at .3913,.3713, and with the red zone .3506 and .3368
-Atm we are makingout withe the ema, which if we can hold it and have a good bounce off of it we can stop buying and it can confirm bullish price action. If it dips below it, it could mean I final acculation zone before we moon.
-MACD is very bullish atm, but if we rise and it gets closer it might be the end short term
-RSI is oversold, so we could suspect sideways movement with massive ranges, slow rise up, or a pure dump. A dump is unlikely in my opinion.
Overall
I've been dca every week, due to the fact of the being in the Brazil market and already having sales. I think this will produce massive gains in the near term, so i'll be holding and will update you guys if we hit lower lows or break the massive resistance.
IDE
NSPR still dippingOkay I'm gonna start off with the news
News
-NSPR beat earnings by 44%, yet still losing money. It has been making more money due to its past performance and not losing as much. We can project that they might be profitable next year.
-Their offering that was held in June came out that it was so they can remain compliant with the exchange. That Friday they have became fully compliant so they won't get delisted.
-On their earnings report they got mostly compliant FDA IDE approval, yet on that they will get fully compliant FDA IDE approval in 45days. This should be on the 27th, so next week, which I labeled on the graph.
-Upcoming catalist: they hope to get into the France and China markets soon. Plus with approval in Brazil we could see that profit from the company in q4/ another earnings beat. Maybe over 100%, yet with COVID not sure, but certain in q1 next year.
TA
-Not sure what to say since an earnings beat should have pushed the price higher, yet we saw a sell off with no FDA IDE approval to common investors liking. At the same time the volume showed it being very low compared to the past showing its just small sellers and yesterday someone bought 200k shares touching our old trading zone.
-the low at .4194 was in the middle of the gap of the intial drop from .80 to .39 then gaping up to .42-.47
Final thoughts
I'm DCAing this stock and think its gonna pay off pretty soon. Recent SEC filing shows that their CFO has sign a contract starting in 2022 that he will get an annual renewal of his job. This shows there is some long term potential if a CFO is entering this contract and wants to see growth in this company or he will get fired. There was alot more in the earnings report like and they don't want to do any more offerings and they also have alot of cash on hand to play with, so upside potential is pretty high.
